T1	HMM 20 39	efficacy and safety
T2	HMM 469 488	safety and efficacy
T3	HMM 1075 1167	CMV infection, CMV disease, rejection, opportunistic infections, and possible drug toxicity.
T4	HMM 1210 1242	6-month incidence of CMV disease
T5	HMM 1443 1467	incidence of CMV disease
T6	HMM 1675 1686	CMV disease
T7	HMM 1817 1843	incidence of CMV infection
T8	HMM 1931 1968	symptomatic herpes-simplex infections
